The Carlat Psychiatry Podcast
SSRIs and Hydroxyzine for Avoidant Restrictive Food Intake Disorder
Mar 4, 2024
Exploring the complexities of Avoidant Restrictive Food Intake Disorder (ARFID) and its treatment modalities, including SSRIs and hydroxyzine. Discussion on diagnosing ARFID, distinguishing it from other eating disorders, and the importance of comprehensive treatment approaches. Insights from a study on using SSRIs and hydroxyzine in children and adolescents for treating ARFID, with positive outcomes observed. Emphasis on dosage recommendations, side effects, and monitoring anxiety levels in severe cases of ARFID management.
17:21
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Early identification of ARFID through screening tools and meal exploration is crucial for tailored treatment approach.
- Combining SSRIs and hydroxyzine may benefit ARFID patients by reducing anxiety, improving weight gain, and managing symptoms effectively.
Deep dives
Understanding avoidant restrictive food intake disorder (ARFID)
Avoidant restrictive food intake disorder is an eating disorder characterized by limited food intake due to sensory sensitivity, fear of adverse consequences from eating, or disinterest in eating. Unlike anorexia or bulimia, it may not involve concerns about body weight or shape. Diagnosis of ARFID can be challenging, especially differentiating it from anorexia. Screening tools and careful exploration of meal habits and preferences are essential to identify ARFID early and tailor treatment.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
